Recombinant Human KLK9 protein (rFc Tag)
种属
Human
纯度
>90 %, SDS-PAGE
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
纯度 | >90 %, SDS-PAGE |
内毒素 | <0.1 EU/μg protein, LAL method |
生物活性 |
Not tested |
来源 | HEK293-derived Human KLK9 protein His16-Asn250 (Accession# Q9UKQ9-1) with a rabbit IgG Fc tag at the C-terminus. |
基因ID | 284366 |
蛋白编号 | Q9UKQ9-1 |
预测分子量 | 52.0 kDa |
SDS-PAGE | 58-68 kDa, reducing (R) conditions |
组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
KLK9, or kallikrein-related peptidase 9, is a member of the human kallikrein-related peptidases family, which is the largest family of secreted serine proteases. These enzymes have diverse expression patterns and physiological roles, and their aberrant activity has been linked to various pathologies such as respiratory diseases, neurodegeneration, skin-barrier dysfunction, and cancer. The serum level of KLK9 has also been suggested to have the potential to be used as a biomarker for asthma. The KLK9 gene was also found to be regulated by steroid hormones, mainly estrogens and progestins, in cancer cell lines.
参考文献:
1. Filippou P, et al. (2017). Clin Proteomics.17;14:4. 2. Yousef GM, et al. (2003). Breast Cancer Res Treat. 78(2):149-58.